DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting May 28, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013 May 16, 2013 • 8:37 AM EDT
DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083 April 10, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting April 1, 2013 • 9:27 AM EDT
DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference March 11, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant March 7, 2013 • 8:00 AM EST
DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors February 28, 2013 • 1:21 PM EST
DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement February 25, 2013 • 7:00 AM EST
DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement February 11, 2013 • 8:30 AM EST